Patents by Inventor Robert L. Melder

Robert L. Melder has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • SYSTEMS AND METHODS FOR ASSESSING THE EFFICACY OF NEUROMODULATION THERAPY
    Publication number: 20210177344
    Abstract: Systems and methods for performing and assessing neuromodulation therapy are disclosed herein. One method for assessing the efficacy of neuromodulation therapy includes positioning a neuromodulation catheter at a target site within a renal blood vessel of a human patient and delivering neuromodulation energy at the target site with the neuromodulation catheter. The method can further include obtaining a measurement related to a dimension of the renal blood vessel via a sensing element of the neuromodulation catheter. The measurement can be compared to a baseline measurement related to the dimension of the renal blood vessel to assess the efficacy of the neuromodulation therapy. In some embodiments, the baseline measurement is obtained via the sensing element of the neuromodulation catheter prior to delivering the neuromodulation energy.
    Type: Application
    Filed: March 2, 2021
    Publication date: June 17, 2021
    Inventors: Michael Neidert, Paul Coates, Robert L. Melder
  • Systems and methods for assessing the efficacy of neuromodulation therapy
    Patent number: 10959669
    Abstract: Systems and methods for performing and assessing neuromodulation therapy are disclosed herein. One method for assessing the efficacy of neuromodulation therapy includes positioning a neuromodulation catheter at a target site within a renal blood vessel of a human patient and delivering neuromodulation energy at the target site with the neuromodulation catheter. The method can further include obtaining a measurement related to a dimension of the renal blood vessel via a sensing element of the neuromodulation catheter. The measurement can be compared to a baseline measurement related to the dimension of the renal blood vessel to assess the efficacy of the neuromodulation therapy. In some embodiments, the baseline measurement is obtained via the sensing element of the neuromodulation catheter prior to delivering the neuromodulation energy.
    Type: Grant
    Filed: January 17, 2019
    Date of Patent: March 30, 2021
    Assignee: Medtronic Ardian Luxembourg S.a.r.l.
    Inventors: Michael Neidert, Paul Coates, Robert L. Melder
  • SYSTEMS AND METHODS FOR ASSESSING THE EFFICACY OF NEUROMODULATION THERAPY
    Publication number: 20190223785
    Abstract: Systems and methods for performing and assessing neuromodulation therapy are disclosed herein. One method for assessing the efficacy of neuromodulation therapy includes positioning a neuromodulation catheter at a target site within a renal blood vessel of a human patient and delivering neuromodulation energy at the target site with the neuromodulation catheter. The method can further include obtaining a measurement related to a dimension of the renal blood vessel via a sensing element of the neuromodulation catheter. The measurement can be compared to a baseline measurement related to the dimension of the renal blood vessel to assess the efficacy of the neuromodulation therapy. In some embodiments, the baseline measurement is obtained via the sensing element of the neuromodulation catheter prior to delivering the neuromodulation energy.
    Type: Application
    Filed: January 17, 2019
    Publication date: July 25, 2019
    Inventors: Michael Neidert, Paul Coates, Robert L. Melder